Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.
Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS. Schweitzer JS, et al. N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872. N Engl J Med. 2020. PMID: 32402162 Free PMC article.
Columnar Injection for Intracerebral Cell Therapy.
Schweitzer JS, Song B, Leblanc PR, Feitosa M, Carter BS, Kim KS. Schweitzer JS, et al. Oper Neurosurg (Hagerstown). 2020 Mar 1;18(3):321-328. doi: 10.1093/ons/opz143. Oper Neurosurg (Hagerstown). 2020. PMID: 31214702 Free PMC article.
Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.
Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS. Song B, et al. Among authors: schweitzer js. J Clin Invest. 2020 Feb 3;130(2):904-920. doi: 10.1172/JCI130767. J Clin Invest. 2020. PMID: 31714896 Free PMC article.
Toward a Personalized Approach to Parkinson's Cell Therapy.
Herrington TM, Schweitzer J, Henchcliffe C, Carter BS, Kim KS. Herrington TM, et al. Mov Disord. 2020 Nov;35(11):2119-2120. doi: 10.1002/mds.28328. Mov Disord. 2020. PMID: 33463754 No abstract available.
Letter to the Editor. Cell therapy for Parkinson's disease.
Schweitzer JS, Herrington TM, Kim KS, Carter BS. Schweitzer JS, et al. J Neurosurg. 2022 Feb 4;136(6):1810-1811. doi: 10.3171/2021.12.JNS212694. J Neurosurg. 2022. PMID: 35120329 No abstract available.
Clinical considerations in Parkinson's disease cell therapy.
Xue J, Wu Y, Bao Y, Zhao M, Li F, Sun J, Sun Y, Wang J, Chen L, Mao Y, Schweitzer JS, Song B. Xue J, et al. Among authors: schweitzer js. Ageing Res Rev. 2023 Jan;83:101792. doi: 10.1016/j.arr.2022.101792. Epub 2022 Nov 17. Ageing Res Rev. 2023. PMID: 36402405 Review.
36 results